Recovery Control Tower Feasibility Pilot (RCT Pilot)
Protocol for a Pilot Interventional Study Evaluating the Efficiency and Safety of a Telemedicine Solution for the Post-Anesthesia Care Unit
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Thaddeus Budelier, MD
- Phone Number: 314-273-8646
- Email: thaddeus.budelier@wustl.edu
Study Locations
-
-
Missouri
-
St. Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
- Adults (18 years and older)
- Undergoing elective surgery at Barnes Jewish Hospital in St. Louis, Missouri will be enrolled.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Recovery Control Tower (RCT)
Clinicians in the RCT will remotely work with PACU clinicians to care for patients assigned to one of the two study bays.
A version of AlertWatch® (AlertWatch, Ann Arbor, Michigan) decision-support software, customized for the PACU environment, will assist clinicians in the RCT to perform core PACU-related functions remotely.
Caregility's iObserver, from the Caregility Cloud™ Virtual Care Platform, will be used for two-way video communication When feasible, RCT clinicians will join handoff activities from the OR to the PACU and discuss pertinent intraoperative events with clinical teams on the ground.
RCT clinicians will document patient specific recovery tasks within AlertWatch to assist in tracking patient recovery progresses.
RCT clinicians will be the initial point of contact for ongoing recovery care, such as order placements.
The attending anesthesiologist in the RCT will assess patients' discharge readiness throughout their PACU stay.
|
Decision-support software, customized for the PACU environment, Interaction between the telemedicine center and the PACU
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time spent in PACU
Time Frame: Day of surgery
|
Time patient enters PACU to time patient leaves PACU
|
Day of surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to PACU sign-out by anesthesia clinician
Time Frame: From the time the patient enters post-anesthesia care unit until time patient leaves post-anesthesia care unit, assessed up to 24 hours after surgery.
|
Time patient enters PACU to time discharge note is signed in EHR by anesthesiologist
|
From the time the patient enters post-anesthesia care unit until time patient leaves post-anesthesia care unit, assessed up to 24 hours after surgery.
|
|
Pain score in PACU
Time Frame: From the time the patient enters post-anesthesia care unit until time patient leaves post-anesthesia care unit, assessed up to 24 hours after surgery.
|
0 to 10 (numeric rating scale [NRS]) - 0 correspond to no pain, ≤ 3 to mild pain, 4-6 to moderate, and scores ≥7 to severe pain
|
From the time the patient enters post-anesthesia care unit until time patient leaves post-anesthesia care unit, assessed up to 24 hours after surgery.
|
|
PONV status in PACU
Time Frame: From the time the patient enters post-anesthesia care unit until time patient leaves post-anesthesia care unit, assessed up to 24 hours after surgery.
|
None, resolved, resolved and tolerable, persists despite treatment, unable to evaluate
|
From the time the patient enters post-anesthesia care unit until time patient leaves post-anesthesia care unit, assessed up to 24 hours after surgery.
|
|
Clinician interactions - Number of contacts RCT clinicians receive from PACU clinicians
Time Frame: From the time the patient enters post-anesthesia care unit until time patient leaves post-anesthesia care unit, assessed up to 24 hours after surgery.
|
Reason for contact will be logged (i.e.
order placement requests, patient assessments)
|
From the time the patient enters post-anesthesia care unit until time patient leaves post-anesthesia care unit, assessed up to 24 hours after surgery.
|
|
Clinician interactions - Number of contacts RCT clinicians make to PACU clinicians for on-the-ground intervention
Time Frame: From the time the patient enters post-anesthesia care unit until time patient leaves post-anesthesia care unit, assessed up to 24 hours after surgery.
|
Reason for contact will be logged
|
From the time the patient enters post-anesthesia care unit until time patient leaves post-anesthesia care unit, assessed up to 24 hours after surgery.
|
|
Safety events - Return to hospital
Time Frame: 24 hours
|
New admission notes, and ED/urgent care notes
|
24 hours
|
|
Safety events - Number of participants with elevation of care
Time Frame: 24 Hours
|
Patients with floor to ICU transfer, and unplanned floor to OR (return to OR)
|
24 Hours
|
|
Safety events - Number of participants with administration of rescue drugs
Time Frame: 24 Hours
|
Events of Naloxone (opioid overdose) and Flumazenil (benzodiazepine overdose) administration
|
24 Hours
|
|
Safety events - Significant event notes
Time Frame: 24 Hours
|
To identify death events
|
24 Hours
|
|
PACU clinician satisfaction
Time Frame: Through study completion, an average of 1 year
|
From monthly surveys
|
Through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Michael S Avidan, MBBCh, Washington University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 202305152
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.